altoprev Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Altoprev, and when can generic versions of Altoprev launch?
Altoprev is a drug marketed by Covis and is included in one NDA.
The generic ingredient in ALTOPREV is lovastatin. There are thirty-three drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the lovastatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Altoprev
A generic version of altoprev was approved as lovastatin by ACTAVIS ELIZABETH on December 17th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for altoprev?
- What are the global sales for altoprev?
- What is Average Wholesale Price for altoprev?
Summary for altoprev
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 126 |
Clinical Trials: | 6 |
Drug Prices: | Drug price information for altoprev |
What excipients (inactive ingredients) are in altoprev? | altoprev excipients list |
DailyMed Link: | altoprev at DailyMed |
Recent Clinical Trials for altoprev
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Amgen | Phase 4 |
Brigham and Women's Hospital | Phase 4 |
National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
Pharmacology for altoprev
Drug Class | HMG-CoA Reductase Inhibitor |
Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
US Patents and Regulatory Information for altoprev
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-001 | Jun 26, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-004 | Jun 26, 2002 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-002 | Jun 26, 2002 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-003 | Jun 26, 2002 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for altoprev
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-004 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-004 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-001 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-002 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Covis | ALTOPREV | lovastatin | TABLET, EXTENDED RELEASE;ORAL | 021316-002 | Jun 26, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for altoprev
See the table below for patents covering altoprev around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1035842 | PREPARATION AMELIOREE D'INHIBITEURS DE LA HMG CoA REDUCTASE A LIBERATION ETENDUE (IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9948488 | ⤷ Sign Up | |
Australia | 2004201520 | ⤷ Sign Up | |
Japan | 2002508311 | ⤷ Sign Up | |
Germany | 69832092 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |